Home » Topics » Disease categories and therapies » Urology

Urology
RSS

Sildenafil continues to demonstrate efficacy in treating ED

Sep. 26, 1997

No Comments

Design, synthesis and evaluation of SNAP-5582 derivatives for BPH

Sep. 26, 1997

No Comments

Synaptic identifies potent, selective alpha1a-adrenoceptor antagonist

Sep. 25, 1997

No Comments

RenaGel safely and effectively binds phosphate in volunteers

Sep. 24, 1997

No Comments

Cytoclonal allowed U.S. patent for PKD treatment

Sep. 23, 1997

No Comments

Abbott investment to fund lupus drug candidate

Sep. 19, 1997

No Comments

Efficacy of GAX-65 demonstrated in pediatric study

Sep. 19, 1997

No Comments

KMD-3213: a newer alpha1-adrenoceptor antagonist for BPH

Sep. 18, 1997

No Comments

Alpha1-adrenoceptor antagonists improve symptoms of BPO, BPH in clinical studies

Sep. 18, 1997

No Comments

Gene Logic and Japan Tobacco enter genomic alliance

Sep. 15, 1997

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Urology
RSS

Sildenafil continues to demonstrate efficacy in treating ED

Design, synthesis and evaluation of SNAP-5582 derivatives for BPH

Synaptic identifies potent, selective alpha1a-adrenoceptor antagonist

RenaGel safely and effectively binds phosphate in volunteers

Cytoclonal allowed U.S. patent for PKD treatment

Abbott investment to fund lupus drug candidate

Efficacy of GAX-65 demonstrated in pediatric study

KMD-3213: a newer alpha1-adrenoceptor antagonist for BPH

Alpha1-adrenoceptor antagonists improve symptoms of BPO, BPH in clinical studies

Gene Logic and Japan Tobacco enter genomic alliance

Today's news in brief

Today's news in brief

STAT6 stat sig? Kaken, J&J $1.2B-plus deal adds oomph to space

GLP-1 receptor agonists continue their global victory tour

AI drives financings, approvals for APAC med-tech in 2024

Urology RSS

Urology
RSS